Global Cancer Therapy and Testing Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08246297

Publication Date:

August 21, 2024

Pages:

128

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Cancer Therapy and Testing
The global Cancer Therapy and Testing market size is projected to grow from US$ 684780 million in 2023 to US$ 1670770 million in 2030; it is expected to grow at a CAGR of 13.6% from 2024 to 2030.
The 鈥淐ancer Therapy and Testing Industry Forecast鈥� looks at past sales and reviews total world Cancer Therapy and Testing sales in 2023, providing a comprehensive analysis by region and market sector of projected Cancer Therapy and Testing sales for 2024 through 2030. With Cancer Therapy and Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Therapy and Testing industry.
This Insight Report provides a comprehensive analysis of the global Cancer Therapy and Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cancer Therapy and Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Cancer Therapy and Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Therapy and Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Therapy and Testing.
The cancer therapy and testing market has been witnessing significant growth over the years and is expected to continue expanding in the future. Several factors contribute to this market growth, including the increasing incidence of cancer globally, advancements in diagnostic technologies, personalized medicine approaches, and a growing emphasis on early detection and targeted therapies.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Therapy and Testing market by product type, application, key players and key regions and countries.
Segmentation by type
Cancer Detection
Cancer Treatment
Segmentation by application
Lung Cancer
Rectal Cancer
Breast Cancer
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Invitae
Foundation Medicine
Guardant Health
Illumina
Sysmex
Abingdon Health
Sophia
NanoEntek
BGI
Diagnosis
Exact Sciences
AstraZeneca
Bayer AG
Johnson & Johnson
Pfizer Inc.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Therapy and Testing Market Size 2019-2030
2.1.2 Cancer Therapy and Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cancer Therapy and Testing Segment by Type
2.2.1 Cancer Detection
2.2.2 Cancer Treatment
2.3 Cancer Therapy and Testing Market Size by Type
2.3.1 Cancer Therapy and Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cancer Therapy and Testing Market Size Market Share by Type (2019-2024)
2.4 Cancer Therapy and Testing Segment by Application
2.4.1 Lung Cancer
2.4.2 Rectal Cancer
2.4.3 Breast Cancer
2.4.4 Other
2.5 Cancer Therapy and Testing Market Size by Application
2.5.1 Cancer Therapy and Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cancer Therapy and Testing Market Size Market Share by Application (2019-2024)
3 Cancer Therapy and Testing Market Size by Player
3.1 Cancer Therapy and Testing Market Size Market Share by Players
3.1.1 Global Cancer Therapy and Testing Revenue by Players (2019-2024)
3.1.2 Global Cancer Therapy and Testing Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Therapy and Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cancer Therapy and Testing by Regions
4.1 Cancer Therapy and Testing Market Size by Regions (2019-2024)
4.2 Americas Cancer Therapy and Testing Market Size Growth (2019-2024)
4.3 APAC Cancer Therapy and Testing Market Size Growth (2019-2024)
4.4 Europe Cancer Therapy and Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Cancer Therapy and Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Cancer Therapy and Testing Market Size by Country (2019-2024)
5.2 Americas Cancer Therapy and Testing Market Size by Type (2019-2024)
5.3 Americas Cancer Therapy and Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Therapy and Testing Market Size by Region (2019-2024)
6.2 APAC Cancer Therapy and Testing Market Size by Type (2019-2024)
6.3 APAC Cancer Therapy and Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cancer Therapy and Testing by Country (2019-2024)
7.2 Europe Cancer Therapy and Testing Market Size by Type (2019-2024)
7.3 Europe Cancer Therapy and Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cancer Therapy and Testing by Region (2019-2024)
8.2 Middle East & Africa Cancer Therapy and Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Cancer Therapy and Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cancer Therapy and Testing Market Forecast
10.1 Global Cancer Therapy and Testing Forecast by Regions (2025-2030)
10.1.1 Global Cancer Therapy and Testing Forecast by Regions (2025-2030)
10.1.2 Americas Cancer Therapy and Testing Forecast
10.1.3 APAC Cancer Therapy and Testing Forecast
10.1.4 Europe Cancer Therapy and Testing Forecast
10.1.5 Middle East & Africa Cancer Therapy and Testing Forecast
10.2 Americas Cancer Therapy and Testing Forecast by Country (2025-2030)
10.2.1 United States Cancer Therapy and Testing Market Forecast
10.2.2 Canada Cancer Therapy and Testing Market Forecast
10.2.3 Mexico Cancer Therapy and Testing Market Forecast
10.2.4 Brazil Cancer Therapy and Testing Market Forecast
10.3 APAC Cancer Therapy and Testing Forecast by Region (2025-2030)
10.3.1 China Cancer Therapy and Testing Market Forecast
10.3.2 Japan Cancer Therapy and Testing Market Forecast
10.3.3 Korea Cancer Therapy and Testing Market Forecast
10.3.4 Southeast Asia Cancer Therapy and Testing Market Forecast
10.3.5 India Cancer Therapy and Testing Market Forecast
10.3.6 Australia Cancer Therapy and Testing Market Forecast
10.4 Europe Cancer Therapy and Testing Forecast by Country (2025-2030)
10.4.1 Germany Cancer Therapy and Testing Market Forecast
10.4.2 France Cancer Therapy and Testing Market Forecast
10.4.3 UK Cancer Therapy and Testing Market Forecast
10.4.4 Italy Cancer Therapy and Testing Market Forecast
10.4.5 Russia Cancer Therapy and Testing Market Forecast
10.5 Middle East & Africa Cancer Therapy and Testing Forecast by Region (2025-2030)
10.5.1 Egypt Cancer Therapy and Testing Market Forecast
10.5.2 South Africa Cancer Therapy and Testing Market Forecast
10.5.3 Israel Cancer Therapy and Testing Market Forecast
10.5.4 Turkey Cancer Therapy and Testing Market Forecast
10.5.5 GCC Countries Cancer Therapy and Testing Market Forecast
10.6 Global Cancer Therapy and Testing Forecast by Type (2025-2030)
10.7 Global Cancer Therapy and Testing Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Invitae
11.1.1 Invitae Company Information
11.1.2 Invitae Cancer Therapy and Testing Product Offered
11.1.3 Invitae Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Invitae Main Business Overview
11.1.5 Invitae Latest Developments
11.2 Foundation Medicine
11.2.1 Foundation Medicine Company Information
11.2.2 Foundation Medicine Cancer Therapy and Testing Product Offered
11.2.3 Foundation Medicine Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Foundation Medicine Main Business Overview
11.2.5 Foundation Medicine Latest Developments
11.3 Guardant Health
11.3.1 Guardant Health Company Information
11.3.2 Guardant Health Cancer Therapy and Testing Product Offered
11.3.3 Guardant Health Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Guardant Health Main Business Overview
11.3.5 Guardant Health Latest Developments
11.4 Illumina
11.4.1 Illumina Company Information
11.4.2 Illumina Cancer Therapy and Testing Product Offered
11.4.3 Illumina Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Illumina Main Business Overview
11.4.5 Illumina Latest Developments
11.5 Sysmex
11.5.1 Sysmex Company Information
11.5.2 Sysmex Cancer Therapy and Testing Product Offered
11.5.3 Sysmex Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sysmex Main Business Overview
11.5.5 Sysmex Latest Developments
11.6 Abingdon Health
11.6.1 Abingdon Health Company Information
11.6.2 Abingdon Health Cancer Therapy and Testing Product Offered
11.6.3 Abingdon Health Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Abingdon Health Main Business Overview
11.6.5 Abingdon Health Latest Developments
11.7 Sophia
11.7.1 Sophia Company Information
11.7.2 Sophia Cancer Therapy and Testing Product Offered
11.7.3 Sophia Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sophia Main Business Overview
11.7.5 Sophia Latest Developments
11.8 NanoEntek
11.8.1 NanoEntek Company Information
11.8.2 NanoEntek Cancer Therapy and Testing Product Offered
11.8.3 NanoEntek Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 NanoEntek Main Business Overview
11.8.5 NanoEntek Latest Developments
11.9 BGI
11.9.1 BGI Company Information
11.9.2 BGI Cancer Therapy and Testing Product Offered
11.9.3 BGI Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 BGI Main Business Overview
11.9.5 BGI Latest Developments
11.10 Diagnosis
11.10.1 Diagnosis Company Information
11.10.2 Diagnosis Cancer Therapy and Testing Product Offered
11.10.3 Diagnosis Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Diagnosis Main Business Overview
11.10.5 Diagnosis Latest Developments
11.11 Exact Sciences
11.11.1 Exact Sciences Company Information
11.11.2 Exact Sciences Cancer Therapy and Testing Product Offered
11.11.3 Exact Sciences Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Exact Sciences Main Business Overview
11.11.5 Exact Sciences Latest Developments
11.12 AstraZeneca
11.12.1 AstraZeneca Company Information
11.12.2 AstraZeneca Cancer Therapy and Testing Product Offered
11.12.3 AstraZeneca Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 AstraZeneca Main Business Overview
11.12.5 AstraZeneca Latest Developments
11.13 Bayer AG
11.13.1 Bayer AG Company Information
11.13.2 Bayer AG Cancer Therapy and Testing Product Offered
11.13.3 Bayer AG Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Bayer AG Main Business Overview
11.13.5 Bayer AG Latest Developments
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Information
11.14.2 Johnson & Johnson Cancer Therapy and Testing Product Offered
11.14.3 Johnson & Johnson Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Johnson & Johnson Main Business Overview
11.14.5 Johnson & Johnson Latest Developments
11.15 Pfizer Inc.
11.15.1 Pfizer Inc. Company Information
11.15.2 Pfizer Inc. Cancer Therapy and Testing Product Offered
11.15.3 Pfizer Inc. Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Pfizer Inc. Main Business Overview
11.15.5 Pfizer Inc. Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂